Sinopep-Allsino is a leading, technologi driven company specialized in developing and manufacturing Peptides, Oligos and small molecules intermediates, APIs. With years of diverse and extensive experience, we have provided high quality products and services to multi-national pharmaceutical corporations and biotechnology companies around the world from preclinical to commercial stages. Sinopep-Allsino currently has three R&D centers supporting manufacturing projects across two manufacturing sites, which met high global quality and EHS standards and approved by US FDA and EDQM.
Year Established: 2004
Total Assets(USD): choose not to disclose
Total Number of Staff: less than 10 person
Annual Turnover(USD) : choose not to disclose
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
Agomelatine In-house Spec.